NeoPharm Co Ltd
KOSDAQ:092730
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NeoPharm Co Ltd
PP&E Gross
NeoPharm Co Ltd
PP&E Gross Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
PP&E Gross
₩30.2B
|
CAGR 3-Years
48%
|
CAGR 5-Years
24%
|
CAGR 10-Years
14%
|
|
|
AmorePacific Corp
KRX:090430
|
PP&E Gross
₩2.3T
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
|
Amorepacific Group
KRX:002790
|
PP&E Gross
₩2.7T
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
|
Cosmax Inc
KRX:192820
|
PP&E Gross
₩925.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
19%
|
|
|
LG H&H Co Ltd
KRX:051900
|
PP&E Gross
₩2.2T
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
PP&E Gross
₩959.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
21%
|
|
NeoPharm Co Ltd
Glance View
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.
See Also
What is NeoPharm Co Ltd's PP&E Gross?
PP&E Gross
30.2B
KRW
Based on the financial report for Dec 31, 2025, NeoPharm Co Ltd's PP&E Gross amounts to 30.2B KRW.
What is NeoPharm Co Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
14%
Over the last year, the PP&E Gross growth was 1%. The average annual PP&E Gross growth rates for NeoPharm Co Ltd have been 48% over the past three years , 24% over the past five years , and 14% over the past ten years .
